Dynamics of anti-malarial antibodies in non-immune patients during and after a first and unique Plasmodium falciparum malaria episode
Open Access
- 26 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 19 (1), 1-8
- https://doi.org/10.1186/s12936-020-03300-x
Abstract
Malaria is a major travel medicine issue. Retrospective confirmation of a malaria episode diagnosed in an endemic area can have relevant implications in transfusional medicine in Europe, where blood donors are excluded from donation on the basis of positive malaria serology. However, there is scarce evidence on the dynamics of anti-malarial antibodies after a first malaria episode in non-immune individuals. The first aim of this study was to describe the dynamics of anti-malarial antibodies in a first malaria episode in non-immune travellers. Secondary objectives were to assess the sensitivity of serology for a retrospective diagnosis in non-immune travellers diagnosed while abroad and to discuss the implications in transfusional medicine. Retrospective analysis of the results of an indirect fluorescence antibody test (IFAT) for malaria available for patients with a first malaria episode by Plasmodium falciparum and admitted at the IRCCS Sacro Cuore Don Calabria hospital in a 14-year period. The antibody titres were collected at baseline and during further follow up visits. Epidemiological, demographic and laboratory test results (including full blood count and malaria parasite density) were anonymously recorded in a study specific electronic Case Report Form created with OpenClinica software. Statistical analysis was performed with SAS software version 9.4. Thirty-six patients were included. Among them, all but two were Europeans (one African and one American). Median length of fever before diagnosis was 2 days (IQR 1–3). Thirty-five patients had seroconversion between day 1 and day 4 from admission, and the titre showed a sharply rising titre, often to a very high level in a few days. Only a single patient remained negative in the first 5 days from admission, after which he was no more tested. Six patients were followed up for at least 2 months, and they all showed a decline in IFAT titre, tending to seroreversion (confirmed in one patient with the longest follow up, almost 4 years). Serology demonstrated reliable for retrospective diagnosis in non-immune travellers. The decline in the anti-malarial titre might be included in the screening algorithms of blood donors, but further studies are needed.Keywords
Other Versions
This publication has 11 references indexed in Scilit:
- Risk of transfusion-transmitted malaria: evaluation of commercial ELISA kits for the detection of anti-Plasmodium antibodies in candidate blood donorsMalaria Journal, 2019
- A systematic review of transfusion-transmitted malaria in non-endemic areasMalaria Journal, 2018
- Controlled Human Malaria Infection: Applications, Advances, and ChallengesInfection and Immunity, 2018
- The role of early detection and treatment in malaria eliminationMalaria Journal, 2016
- Chronic malaria and hyper-reactive malarial splenomegaly: a retrospective study on the largest series observed in a non-endemic country.Malaria Journal, 2016
- Health workers’ compliance to rapid diagnostic tests (RDTs) to guide malaria treatment: a systematic review and meta-analysisMalaria Journal, 2016
- Imported Malaria in Immigrants to Italy: A Changing Pattern Observed in North Eastern ItalyJournal of Travel Medicine, 2009
- Validity of Malaria Diagnosis in Nonimmune Travelers in Endemic AreasJournal of Travel Medicine, 2008
- DO AFRICAN IMMIGRANTS LIVING IN FRANCE HAVE LONG-TERM MALARIAL IMMUNITY?The American Journal of Tropical Medicine and Hygiene, 2005
- Retrospective Immunodiagnosis of Malaria in Nonimmune Travelers Returning From the TropicsJournal of Travel Medicine, 1995